References: 1. Kesavapany, S., Li, B.S., Amin, N., Zheng, Y., Grant, P., Pant, H.C. (2004). Neuronal cyclin-dependent kinase 5 : role in nervous system function an its specific inhibition by the Cdk5 inhibitory peptide. Biochimica et Biophysica Acta 1697, 143-153 ?
2. Rosenbum, JS. Cdk5 acts as a surveillance system in the nervous system. In: Yamaguchi M, editor. New developments in signal transduction research. Nova Science Publishers ; 2013
3. Shea, B. T., Zheng, Y., Ortiz, D., Pant, H. C. (2004). Cyclin-Dependent Kinase 5 Increases Perikaryal Neurofilament Phosphorylation and Inhibits Neurofilament Axonal Transport in Response to Oxidative Stress. J. Neurosci. Res. 76, 795-800. ?
4. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., Tsai, L. H. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40: 471–483.
5. Shukla, V., Zheng, Y. L., Mishra, S. K., Amin, N. D., Steiner, J., Grant, P., Kesavapany, S., Pant, H. C. (2013). A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J. 27(1): 174–186.
6. Yushan, R., Wenjie, C., Suning, H., Yiwu, D., Tengfei, Z., Madushi, W. M., Feifei, L., Changwen, Z., Xin, W., Roodrajeetsing, G., Zuyun, L., Gang, C. (2015). Insights into the clinical value of cyclin-dependent kinase 5 in glioma : a retrospective study. World J Surg Oncol. 13: 223.
7. Xie, Q., Wu, Q., Horbinski, C. M., Flavahan, W. A., Yang, K., Zhou, W., Dombrowski, S. M., Huang, Z., Fang, X., Shi, Y., Ferguson, A. N., Kashatus, D. F., Bao, S., Rich, J. N. (2015). Mitochondrial control by DRP1 in brain tumor initiating cells. Nature Neuroscience. 18 : 501-510
8. Lu, P. J., Wulf, G., Zhou, X. Z., Davies, P., and Lu, K. P. (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784 –788